Metabolism pathways and use of heptral in chronic liver diseases

Il'chenko, L.I.; Vinnitskaia, E.V.

Eksperimental'naia i Klinicheskaia Gastroenterologiia 2: 62

2002


ISSN/ISBN: 1682-8658
PMID: 12046390
Document Number: 541471
Heptral (Ademetionine) plays one of the main functions in the intermediate metabolism, takes part in the processes of methylation and transulfurization and aminopropylation. The use of Heptral in patients with chronic liver diseases with accompanying holystase and encephalopathy of different degree, at depressions, related to alcohol and toxic liver disorders, is pathogenically reasoned for prevention of liver encephalopathy.

Document emailed within 1 workday
Secure & encrypted payments